RNA Outsourcing Resources

1. Building Local Biomanufacturing Capacity In South Africa 2/11/2025

   Biovac evolved from a vaccine supplier to a biopharmaceutical innovator, providing a blueprint for expanding Africa's vaccine manufacturing capacity. Gain valuable insights from their journey.

2. Learn How Compliance-Ready LC-MS Workflows for Oligonucleotides Can Expand your Analytical Services Portfolio 2/22/2022

   CMO invests in solution to ensure data integrity and meet regulatory requirements as they expand their oligonucleotide manufacturing and analysis services.

3. Navigating Challenges In Progressing Breakthrough RNA Therapeutics 5/14/2024

   RNA therapeutics hold immense promise for precision treatment, but their development faces challenges. A CDMO with adaptable platforms and flexible timelines can help reduce time and costs.

4. mRNA Synthesis Reagents And Manufacturing 8/14/2023

   As novel mRNA therapies are starting to enter clinical stages of development, Aldevron is providing critical support in a number of ways with specialized products and services.

5. Contract Design And Development Vs. In-House: Finding The Best Fit 11/18/2024

   Outsourcing medical device R&D to Contract Development Organizations (CDOs) aids innovation, scales resources, and overcomes constraints. Strategic evaluation ensures successful partnerships.

6. Treating Deficiencies In Employee Training And Mentorship 5/3/2024

   Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.

7. The Current And Future Value Of mRNA Vaccines And Therapeutics 2/4/2026

   Discover how decades of research have propelled mRNA technology to the forefront of therapeutic development and learn how our expertise is advancing mRNA drug development.

8. Clinical Research Is A Delicate Ecosystem 4/18/2024

   Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors.

9. The M.O. Behind Choosing A CDMO: Three Considerations For New Drug Developers 11/29/2021

   The greatest challenge in drug development can be finding a team capable of carrying a molecule through the complexities that lie between the research lab and the patient’s bedside. Discover three considerations that build a foundation for partnership.

10. What Sponsors Get Wrong When Selecting A CRO 3/9/2026

    Gene therapy immunogenicity requires platforms, judgment, and regulatory fluency beyond ADA norms. Relying on biologics criteria creates gaps; CGT expertise ensures reliable, interpretable results.